Literature DB >> 15623499

Differential expression of CD150 (SLAM) on monocytes and macrophages in chronic inflammatory contexts: abundant in Crohn's disease, but not in multiple sclerosis.

D Theil, C Farina, E Meinl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15623499      PMCID： PMC1770551          DOI： 10.1136/jcp.2004.019323

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

Review 1.  New concepts in the immunopathogenesis of multiple sclerosis.

Authors:  Bernhard Hemmer; Juan J Archelos; Hans-Peter Hartung
Journal:  Nat Rev Neurosci       Date:  2002-04       Impact factor: 34.870

2.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

3.  Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines.

Authors:  Cinthia Farina; Diethilde Theil; Barbara Semlinger; Reinhard Hohlfeld; Edgar Meinl
Journal:  Int Immunol       Date:  2004-04-19       Impact factor: 4.823

4.  Bacterial flagellin is a dominant antigen in Crohn disease.

Authors:  Michael J Lodes; Yingzi Cong; Charles O Elson; Raodoh Mohamath; Carol J Landers; Stephan R Targan; Madeline Fort; Robert M Hershberg
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

5.  Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction.

Authors:  H Babbe; A Roers; A Waisman; H Lassmann; N Goebels; R Hohlfeld; M Friese; R Schröder; M Deckert; S Schmidt; R Ravid; K Rajewsky
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307
  5 in total
  7 in total

1.  Canine distemper virus infection requires cholesterol in the viral envelope.

Authors:  Heidi Imhoff; Veronika von Messling; Georg Herrler; Ludwig Haas
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

2.  SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells.

Authors:  Bence Réthi; Péter Gogolák; Istvan Szatmari; Agota Veres; Erika Erdôs; Laszlo Nagy; Eva Rajnavölgyi; Cox Terhorst; Arpád Lányi
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

3.  High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.

Authors:  Yoshimi Enose-Akahata; Eiji Matsuura; Unsong Oh; Steven Jacobson
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

Review 4.  SLAMF6 in health and disease: Implications for therapeutic targeting.

Authors:  Burcu Yigit; Ninghai Wang; Roland W Herzog; Cox Terhorst
Journal:  Clin Immunol       Date:  2018-10-23       Impact factor: 3.969

5.  SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.

Authors:  Maria Yurchenko; Astrid Skjesol; Liv Ryan; Gabriel Mary Richard; Richard Kumaran Kandasamy; Ninghai Wang; Cox Terhorst; Harald Husebye; Terje Espevik
Journal:  J Cell Biol       Date:  2018-02-12       Impact factor: 10.539

6.  Neutrophil autophagy during human active tuberculosis is modulated by SLAMF1.

Authors:  Joaquín Miguel Pellegrini; Florencia Sabbione; María Paula Morelli; Nancy Liliana Tateosian; Florencia Andrea Castello; Nicolás Oscar Amiano; Domingo Palmero; Alberto Levi; Lorena Ciallella; María Isabel Colombo; Analía Silvina Trevani; Verónica Edith García
Journal:  Autophagy       Date:  2020-10-04       Impact factor: 16.016

7.  Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.

Authors:  Hemalatha Babu; Anoop T Ambikan; Erin E Gabriel; Sara Svensson Akusjärvi; Alangudi Natarajan Palaniappan; Vijila Sundaraj; Naveen Reddy Mupanni; Maike Sperk; Narayanaiah Cheedarla; Rathinam Sridhar; Srikanth P Tripathy; Piotr Nowak; Luke Elizabeth Hanna; Ujjwal Neogi
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.